Nearly 1 in 6 Kids on GLP-1s Developed This Problem Within a Year
Gizmodo • • health
Key Points:
- Recent research from Northwestern University found that nearly 17% of children and teens prescribed GLP-1 medications like Ozempic developed new nutritional deficiencies within a year, with vitamin D deficiency being the most common.
- The study analyzed medical records of about 2,000 children aged 10 to 17 without prior deficiencies, highlighting an underrecognized risk associated with GLP-1 receptor agonist therapy in pediatric patients.
- Childhood obesity affects over 20% of youth, and while GLP-1 drugs are effective for obesity and type 2 diabetes, their long-term nutritional impacts on children remain insufficiently understood.
- The observational study cannot definitively link GLP-1 use to deficiencies but notes that only a small fraction of patients received timely dietary counseling, suggesting gaps in proactive nutritional management.
- Researchers emphasize the need for closer monitoring and early nutritional intervention to prevent harm in children treated with GLP-1 medications during critical developmental periods.
